The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / U.K. Cost Body Finally Approves Limited Use of GSK’s Lupus Drug

U.K. Cost Body Finally Approves Limited Use of GSK’s Lupus Drug

May 12, 2016 • By Reuters Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

LONDON (Reuters)—Britain’s healthcare cost watchdog has finally approved GlaxoSmithKline’s lupus drug Benlysta (belimumab) for limited use, after rejecting it since 2011 on the grounds that it failed to offer good value for money.

You Might Also Like
  • GSK Wins U.S. Shingles Vaccine Approval, U.K. Nod for Gene Therapy
  • AstraZeneca Lupus Drug Fails to Meet Main Goal in Study
  • GSK, Astra, J&J Link with Universities in New Drug Research Fund

The National Institute for Health and Care Excellence (NICE) said on Tuesday that the drug would be made available under a managed access scheme between GSK and the National Health Service (NHS) in England.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

This requires the treatment to be reviewed by NICE after three years, during which time further data will be collected on its benefit to patients.

Benlysta, the first new treatment for lupus in a half-century, was approved in Europe five years ago but there has been debate about just how well it helps in treating lupus.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

GSK will provide the medicine to the NHS at an undisclosed discount.

Filed Under: Conditions, Drug Updates, SLE (Lupus) Tagged With: International, Lupus, National Health Service (NHS), systemic lupus erythematosus (SLE)

You Might Also Like:
  • GSK Wins U.S. Shingles Vaccine Approval, U.K. Nod for Gene Therapy
  • AstraZeneca Lupus Drug Fails to Meet Main Goal in Study
  • GSK, Astra, J&J Link with Universities in New Drug Research Fund
  • Don’t Bank on U.S. Drug Price Rises, Warns GSK Boss

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.